Physician

Marthe Ngongang Dika, M.D.

According to 2025 Medicare claims, Marthe Dika, M.D. (NPI: 1043604424) practices dermatology in the Racine-Mount Pleasant, WI market, with the plurality of this provider's patient population coming from Racine, WI. This provider's primary affiliated billing organization is M DIKA DERMATOLOGY (NPI: 1740867332) and primary practice location at 53105-9998.

Dika's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 227 traditional Medicare patients, billed 1,403 HCPCS/CPT codes, and received $93,234 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 431 prescription claims across 169 beneficiaries totaling $474,401 in drug costs, led by Taltz Syringe (Ixekizumab). Open Payments data shows 63 records totaling $20,515. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,962 to $93,234. Similarly, Part D prescription costs have risen steadily, from $73,905 to $474,401. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$48K$96K2019 Medicare payment: $8,962 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $34,569 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $23,332 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $44,835 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $96,103 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $93,234 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201970168$8,962
20201932,124$34,569
2021148523$23,332
2022197779$44,835
20232961,439$96,103
20242271,403$93,234

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$237K$474K2016 Drug cost: $73,905 (USD; Tot_Drug_Cst)2017 Drug cost: $155,875 (USD; Tot_Drug_Cst)2018 Drug cost: $124,919 (USD; Tot_Drug_Cst)2019 Drug cost: $96,230 (USD; Tot_Drug_Cst)2020 Drug cost: $51,690 (USD; Tot_Drug_Cst)2021 Drug cost: $209,337 (USD; Tot_Drug_Cst)2022 Drug cost: $226,423 (USD; Tot_Drug_Cst)2023 Drug cost: $323,740 (USD; Tot_Drug_Cst)2024 Drug cost: $474,401 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201699256$73,905
2017140442$155,875
201894231$124,919
2019112243$96,230
2020177398$51,690
2021158388$209,337
2022146337$226,423
2023197449$323,740
2024169431$474,401

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more98174$82
17110Destruction of skin growth, 1-14 growths7184$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7085$54
17000Destruction of precancer skin growth, 1 growth7192$34
17003Destruction of precancer skin growth, 2-14 growths61258$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz SyringeIxekizumab11308$306,742
Dupixent PenDupilumab14392$54,299
AcitretinAcitretin16660$5,355
FluorouracilFluorouracil30805$1,983
Clobetasol PropionateClobetasol Propionate521,402$1,721

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.62$3,364GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.1$17,151SANOFI US SERVICES INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marthe Ngongang Dika, M.D.?

Tedicare shows public-source Medicare data for Marthe Ngongang Dika, M.D. (NPI 1043604424), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marthe Ngongang Dika, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marthe Ngongang Dika, M.D.?

Marthe Ngongang Dika, M.D. is linked to M DIKA DERMATOLOGY (billing NPI 1740867332) in the available physician profile data.

Does Marthe Ngongang Dika, M.D. have Open Payments data?

Marthe Ngongang Dika, M.D. has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.